|
US6890539B2
(en)
|
1998-12-22 |
2005-05-10 |
Microscience, Ltd. |
Genes and proteins, and their use
|
|
EA004444B1
(ru)
|
1998-12-22 |
2004-04-29 |
Майкросайенс Лимитед |
Гены и белки и их применение
|
|
ATE439372T1
(de)
|
2000-10-27 |
2009-08-15 |
Novartis Vaccines & Diagnostic |
Nukleinsäuren und proteine von gruppen a und b- streptokokken
|
|
JP4875490B2
(ja)
|
2003-07-31 |
2012-02-15 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
|
|
US8945589B2
(en)
|
2003-09-15 |
2015-02-03 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for Streptococcus agalactiae
|
|
WO2006042027A2
(en)
*
|
2004-10-08 |
2006-04-20 |
Novartis Vaccines And Diagnostics Inc. |
Immunogenic and therapeutic compositions for streptococcus pyogenes
|
|
EP1801235A1
(en)
*
|
2005-12-20 |
2007-06-27 |
Institut Pasteur |
Rapid detection of the "high virulent" ST-17 clone of Group B streptococcus
|
|
WO2008020308A2
(en)
*
|
2006-06-19 |
2008-02-21 |
Mutabilis Sa |
Identification of genes implicated in the virulence of streptococcus agalactiae
|
|
EP2063911A2
(en)
*
|
2006-07-26 |
2009-06-03 |
Novartis Ag |
Immunogenic compositions for gram positive bacteria
|
|
CA2699513C
(en)
|
2007-09-12 |
2018-03-13 |
Novartis Ag |
Gas57 mutant antigens and gas57 antibodies
|
|
EP2135877A1
(en)
|
2008-06-19 |
2009-12-23 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof
|
|
US8147849B2
(en)
|
2009-02-20 |
2012-04-03 |
Novartis Ag |
Protective antigens for group B Streptococcus hypervirulent strains
|
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
|
CN107126557A
(zh)
|
2009-06-29 |
2017-09-05 |
健诺西生物科学公司 |
抗肺炎链球菌的疫苗和组合物
|
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
|
WO2012100234A1
(en)
|
2011-01-20 |
2012-07-26 |
Genocea Biosciences, Inc. |
Vaccines and compositions against streptococcus pneumoniae
|
|
KR20140026372A
(ko)
*
|
2011-02-02 |
2014-03-05 |
이무노퓨처 아이앤씨. |
혈액-뇌 장벽을 투과하는 약물 전달체, 펩티드 및 이의 용도
|
|
EP2557424A1
(en)
|
2011-08-11 |
2013-02-13 |
InGen Biosciences |
Method for diagnosing Streptococcus, Enterococcus and Pepstostreptococcus genera infections
|
|
WO2013124473A1
(en)
*
|
2012-02-24 |
2013-08-29 |
Novartis Ag |
Pilus proteins and compositions
|
|
EP2831250B1
(en)
*
|
2012-03-30 |
2021-11-24 |
DuPont US Holding, LLC |
Enzymes useful for peracid production
|
|
AR092896A1
(es)
|
2012-10-03 |
2015-05-06 |
Novartis Ag |
Composiciones inmunogenicas
|
|
WO2015008214A1
(en)
*
|
2013-07-16 |
2015-01-22 |
Universite De Lausanne |
Bacterial lysins and uses thereof
|
|
US10245310B2
(en)
*
|
2014-08-05 |
2019-04-02 |
Glaxosmithkline Biologicals Sa |
Carrier molecule for antigens
|
|
AU2017214441B2
(en)
|
2016-02-04 |
2021-08-19 |
Genovis Ab |
New Streptococcal proteases
|
|
WO2018204153A1
(en)
*
|
2017-05-02 |
2018-11-08 |
Venomyx, Inc. |
Composition and methods for treating snake envenomation
|
|
WO2018237010A2
(en)
*
|
2017-06-20 |
2018-12-27 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Vaccine compositions and methods of using the same
|
|
PL239045B1
(pl)
*
|
2018-01-09 |
2021-11-02 |
Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk |
Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
|
|
CA3103442A1
(en)
*
|
2018-06-13 |
2019-12-19 |
Gen-Probe Incorporated |
Compositions and methods for detecting group b streptococcus nucleic acid
|
|
KR20210055694A
(ko)
|
2018-08-06 |
2021-05-17 |
메디카인 인코포레이티드 |
Il-2 수용체 결합 화합물
|
|
KR20220110207A
(ko)
|
2019-11-05 |
2022-08-05 |
메디카인 인코포레이티드 |
IL-2RβγC 결합 화합물
|
|
CA3160722A1
(en)
*
|
2019-12-06 |
2021-06-10 |
Theratechnologies Inc. |
Sortilin binding conjugate compounds, compositions and uses thereof for treating cancer
|
|
US11746139B2
(en)
|
2020-02-03 |
2023-09-05 |
Medikine, Inc. |
IL-7Rαγc binding compounds
|
|
US20230127948A1
(en)
*
|
2020-02-12 |
2023-04-27 |
The Broad Institute, Inc. |
Field deployable crispr-cas diagnostics and methods of use thereof
|
|
US11639523B2
(en)
|
2020-03-23 |
2023-05-02 |
The Broad Institute, Inc. |
Type V CRISPR-Cas systems and use thereof
|
|
WO2022026534A1
(en)
*
|
2020-07-28 |
2022-02-03 |
Kansas State University Research Foundation |
Sars-cov-2 immunogenic compositions and methods for protecting against sars-cov-2 clinical signs
|
|
EP4268901A3
(en)
*
|
2020-11-04 |
2024-01-17 |
Medikine, Inc. |
Il-2r beta-gamma c binding compounds and uses thereof
|
|
US11999771B2
(en)
|
2022-04-07 |
2024-06-04 |
Medikine, Inc. |
IL-7Rαγc ligand immunoglobulin fusion proteins
|
|
WO2025017062A1
(en)
*
|
2023-07-18 |
2025-01-23 |
Intervet International B.V. |
New type of streptococcus agalactiae serotype ia bacterium and vaccines thereof
|
|
WO2025151408A1
(en)
*
|
2024-01-08 |
2025-07-17 |
Denali Therapeutics Inc. |
Compositions and methods for modulating tau expression
|
|
WO2025250877A1
(en)
*
|
2024-05-31 |
2025-12-04 |
Saliogen Therapeutics, Inc. |
Mobile genetic elements from myotis myotis
|